WeVote
Log In

Bill

Bill

AB 259

Establishes provisions governing prescription drugs. (BDR 40-165)

2025 Regular Session Introduced by Natha Anderson and 1 co-sponsor

AB 259 would cap Nevada drug purchases and reimbursements at the federal Medicare maximum fair price for certain drugs, with civil penalties for violations.

Vetoed by the Governor.
0

WeVote — Public opinion

No community votes yet. Be the first to weigh in from the Vote tab.

Bill text & amendments

AB 259 Opposition Letter submitted by William S. Reid, Vice-President, State Government Affairs, Lilly Corporation AB 259 Opposition Letter submitted by Ranier Simons, Director of State Policy, PDABs Community Access National Network (CANN) AB259 Multiple Letters of Testimony in Opposition AB259 Work Session Document and Amendment AB259 Prescription Drugs and the Commonly Treated Conditions submitted by Assemblymember Venicia Considine AB259 Letter of Testimony in Opposition Will Dane AB259 Medicare Announces Results of First Round Historic Drug Price Negotiations submitted by Assemblymember Venicia Considine AB259 Letter of Testimony in Opposition Jeani Smith AB 259 Opposition Letter submitted by Biotechnology Innovation Organization AB 259 Opposition Letter submitted by EACH/PIC Coalition AB259 Proposed Amendment submitted by Assemblymember Venicia Considine